Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PLRZ
stocks logo

PLRZ

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Polyrizon Ltd (PLRZ.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Polyrizon Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

PLRZ News & Events

Events Timeline

(ET)
2025-12-04
14:00:00
Polyrizon Sees 7,453.25% Surge in Search Activity
select
2025-12-03 (ET)
2025-12-03
12:30:00
Polyrizon Sees 5,728.31% Surge in Search Activity
select
2025-12-03
09:30:00
Polyrizon's New Naloxone Hydrogel Shows Stronger Adhesion
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
02:45 AMBenzinga
PinnedPolyrizon Shares Surge Following New Data Indicating Naloxone Gel Exceeds Performance of Existing Spray

  • Polyrizon Stock Surge: Polyrizon Ltd. (NASDAQ: PLRZ) experienced a significant stock increase of 96.47%, reaching $13.92, with trading volume spiking to 18.56 million shares, far exceeding the average of 2.62 million.

  • New Preclinical Data: The company released promising preclinical data indicating that its naloxone hydrogel formulation adheres to nasal tissue longer than a currently marketed intranasal naloxone spray, suggesting improved drug delivery.

  • Research Findings: In an ex-vivo study using rabbit nasal mucosa, Polyrizon's hydrogel demonstrated significantly higher mucoadhesion levels compared to the commercial product, which may enhance drug absorption and effectiveness in emergency situations.

  • CEO's Statement: Tomer Izraeli, CEO of Polyrizon, emphasized that the results validate the potential of their T&T hydrogel platform, marking a crucial milestone in advancing their Naloxone program.

[object Object]
Preview
9.0
12-04NASDAQ.COM
PinnedPolyrizon Rises Following Encouraging Mucoadhesion Findings for Naloxone Hydrogel

  • Polyrizon's Hydrogel Findings: Polyrizon Ltd. reported promising preclinical results showing that its Trap and Target naloxone hydrogel adheres to nasal tissue longer than existing intranasal naloxone sprays, leading to a 155% increase in share price during premarket trading.

  • Comparison with Commercial Products: In a study using an ex-vivo rabbit model, Polyrizon's hydrogel demonstrated significantly higher mucoadhesion compared to commercial naloxone sprays, suggesting improved drug delivery for emergency opioid overdose treatments.

  • Importance of Mucoadhesion: Enhanced mucoadhesion is critical for intranasal drug delivery, as it can lead to prolonged contact at the nasal site, improving absorption and potentially speeding up the onset of action.

  • CEO's Statement: Tomer Izraeli, CEO of Polyrizon, emphasized that the findings validate the potential of their hydrogel platform and its advantages in intranasal drug delivery.

[object Object]
Preview
9.5
17:53 PMBenzinga
Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Ulta Beauty Earnings Report: Ulta Beauty, Inc. reported third-quarter earnings of $5.14 per share, surpassing analyst expectations, and raised its full-year GAAP EPS guidance, leading to a 5.7% increase in share price during pre-market trading.

  • Other Notable Gainers: Several stocks saw significant pre-market gains, including Lion Group Holding Ltd (+57.3%), SMX (+42.9%), and Akanda Corp (+30.1%), following positive developments and shareholder approvals.

  • Stocks Experiencing Losses: Sportsman’s Warehouse Holdings Inc. faced an 18.8% drop after disappointing third-quarter results, while Protara Therapeutics Inc. fell 14.3% due to a public offering announcement.

  • Market Overview: The overall market showed mixed results, with some companies like Rubrik, Inc. and Zumiez Inc. reporting strong earnings and positive outlooks, while others like Hewlett Packard Enterprise Co. and Docusign Inc. reported weaker-than-expected results.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Polyrizon Ltd (PLRZ) stock price today?

The current price of PLRZ is 14.5 USD — it has increased 104.51 % in the last trading day.

arrow icon

What is Polyrizon Ltd (PLRZ)'s business?

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..

arrow icon

What is the price predicton of PLRZ Stock?

Wall Street analysts forecast PLRZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PLRZ is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Polyrizon Ltd (PLRZ)'s revenue for the last quarter?

Polyrizon Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Polyrizon Ltd (PLRZ)'s earnings per share (EPS) for the last quarter?

Polyrizon Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Polyrizon Ltd (PLRZ)'s fundamentals?

The market is revising No Change the revenue expectations for PLRZ for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 136.93%.
arrow icon

How many employees does Polyrizon Ltd (PLRZ). have?

Polyrizon Ltd (PLRZ) has 1 emplpoyees as of December 05 2025.

arrow icon

What is Polyrizon Ltd (PLRZ) market cap?

Today PLRZ has the market capitalization of 15.10M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free